The risks of unproven drugs for coronavirus
Bernie Sanders ends his White House bid. Sean Sullivan discusses the impact of his campaign. There have been only a few anecdotal studies showing benefits of antimalarial drugs in coronavirus patients, yet the FDA has authorized the widespread use of the drugs. Chris Rowland reports. Phil Rucker on why Trump has been pushing the drug hydroxychloroquine, despite warnings from some public health officials about dangerous side effects and uncertain results. And Style editor Steve Kolowich remembers musician John Prine, who died Tuesday of coronavirus complications.
FDA authorizes widespread use of unproven drugs to treat coronavirus, saying possible benefit outweighs risk.
‘What do you have to lose?’: Inside Trump’s embrace of a risky drug against coronavirus.
Subscribe to The Washington Post: https://postreports.com/offer
Download from Google Play
Download from App Store